Quick Answer
X4 Pharmaceuticals, Inc reported Common Stock Shares Outstanding of 90.91 million shares for the year ending 2025.
- X4 Pharmaceuticals, Inc showed an increase of +1,495.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from X4 Pharmaceuticals, Inc's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: 14.29 million shares | Q2 2018: 14.32 million shares | Q3 2018: 14.32 million shares | Q1 2019: 6.72 million shares | Q2 2019: 12.43 million shares | Q3 2019: 12.44 million shares | Q1 2020: 16.14 million shares | Q3 2020: 16.29 million shares | Q1 2021: 23.43 million shares | Q2 2021: 24.58 million shares | Q3 2021: 24.71 million shares | Q1 2022: 30.81 million shares | Q2 2022: 30.99 million shares | Q3 2022: 68.73 million shares | Q1 2023: 122.21 million shares | Q2 2023: 164.42 million shares | Q3 2023: 164.71 million shares | Q1 2024: 167.94 million shares | Q2 2024: 168.20 million shares | Q3 2024: 168.51 million shares | Q1 2025: 5.79 million shares | Q2 2025: 7.96 million shares | Q3 2025: 25.15 million shares.
- Over the full 9 years of available data (2017 to 2025), X4 Pharmaceuticals, Inc's Common Stock Shares Outstanding has grown by 536.0%.
- Historical annual values: Fiscal year 2025: 90.91 million shares | Fiscal year 2024: 5.70 million shares | Fiscal year 2023: 167.43 million shares | Fiscal year 2022: 121.67 million shares | Fiscal year 2021: 28.13 million shares | Fiscal year 2020: 16.31 million shares | Fiscal year 2019: 16.13 million shares | Fiscal year 2018: 351,652 shares | Fiscal year 2017: 14.29 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: